Citius Oncology CTOR
NASDAQ CTOR
$0.71 +0.04 (+5.24%)
As of: Oct 21, 2026 · 9:41 AM EDT

Citius Oncology (CTOR) Non-Current Debt (2025 - 2026)

Updated

Citius Oncology's Non-Current Debt came in at $3.8 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), unchanged from the prior quarter.

Analysis

Citius Oncology (CTOR) Non-Current Debt (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,140.41 Bn 1,108.99 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 618.57 Bn 537.10 Bn 17.26 Bn 37.34 Bn
3 AbbVie 509.95 Bn 483.06 Bn 12.70 Bn 62.48 Bn
4 Merck 366.63 Bn 321.01 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.47 Bn 262.46 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 263.21 Bn 236.89 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.71 Bn 192.11 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 193.05 Bn 167.25 Bn 6.22 Bn 23.83 Bn
9 Pfizer 171.45 Bn 118.10 Bn 10.94 Bn 60.50 Bn
10 Citius Oncology 76.18 Mn 45.76 Mn 1.00 Mn 3.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.80 Mn
Mar 31, 2026 3.80 Mn
Sep 30, 2025 3.80 Mn
API Access

Citius Oncology Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=CTOR&period=max&api_key=YOUR_API_KEY